Behavioral
desensitization
desensitization is a behavioral intervention with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
25%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
recruiting125%
unknown250%
completed125%
Recent Activity
1 active trials
Showing 4 of 4
unknownnot_applicable
A Comparison of Two Treatments for CRPS and Changes in Resting-State Connectivity of Cerebral Networks.
NCT02753335
unknown
Immune Response in Desensitized Patients
NCT05785936
recruitingnot_applicable
Lipofilling Versus Conservative Treatment in Fingertips Injuries Sequelae
NCT04076397
completedphase_2
Neuroendocrine Mechanisms in Behavioral Treatment of Insomnia
NCT00303342
Clinical Trials (4)
Showing 4 of 4 trials
NCT02753335Not Applicable
A Comparison of Two Treatments for CRPS and Changes in Resting-State Connectivity of Cerebral Networks.
NCT05785936
Immune Response in Desensitized Patients
NCT04076397Not Applicable
Lipofilling Versus Conservative Treatment in Fingertips Injuries Sequelae
NCT00303342Phase 2
Neuroendocrine Mechanisms in Behavioral Treatment of Insomnia
All 4 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 4